Related Experiment Video

Updated: May 29, 2026

Intubation-mediated Intratracheal (IMIT) Instillation: A Noninvasive, Lung-specific Delivery System
08:00

Intubation-mediated Intratracheal (IMIT) Instillation: A Noninvasive, Lung-specific Delivery System

Published on: November 17, 2014

Inhaled antibiotics for gram-negative respiratory infections

Ryan Hudson1, Brooke Olson Blair

  • 1Theravance, Inc., 901 Gateway Blvd, South San Francisco, CA 94080, USA. rhudson@theravance.com

Future Medicinal Chemistry
|September 28, 2011
PubMed

Insights

Inhaled antimicrobial drugs effectively treat Gram-negative respiratory infections, particularly Pseudomonas aeruginosa in cystic fibrosis patients. Continued research is vital for next-generation agents against evolving resistant bacteria.

Area of Science:

  • Respiratory Medicine
  • Infectious Diseases
  • Pharmacology

Background:

  • Opportunistic Gram-negative respiratory infections arise from various disease states.
  • Inhalation is a direct, yet historically underutilized, route for antimicrobial drug delivery to the respiratory tract.

Purpose of the Study:

  • To review the current landscape of inhaled antimicrobial therapies for respiratory tract infections.
  • To highlight the need for novel antimicrobial agents with improved resistance profiles.

Main Methods:

  • Review of approved inhaled antimicrobial agents and their indications.
  • Discussion of technological advancements in inhalation devices and drug formulations.
  • Analysis of the challenges posed by antimicrobial resistance in respiratory pathogens.

Main Results:

  • Approved inhaled antimicrobials are primarily indicated for Pseudomonas aeruginosa in cystic fibrosis, significantly reducing exacerbations and hospitalizations.
  • Technological progress has expanded the range of antimicrobial classes suitable for inhalation.
  • Pathogen adaptation necessitates the continuous development of new antimicrobial agents.

Conclusions:

  • Inhaled therapies have proven effective for specific respiratory infections like cystic fibrosis-associated Pseudomonas aeruginosa.
  • Advancements in drug delivery systems enable broader investigation of inhaled antimicrobials.
  • Discovering novel compounds with superior resistance profiles is crucial to combat evolving bacterial resistance.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...